{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:40:36Z","timestamp":1792201236425,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":1037,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["RC1GM091739"],"award-info":[{"award-number":["RC1GM091739"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM121601"],"award-info":[{"award-number":["R01GM121601"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM122775"],"award-info":[{"award-number":["R01GM122775"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM116184"],"award-info":[{"award-number":["R01GM116184"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM114731"],"award-info":[{"award-number":["P30GM114731"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI062629"],"award-info":[{"award-number":["U19AI062629"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1111\/jth.14642","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T06:50:15Z","timestamp":1569307815000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis"],"prefix":"10.1016","volume":"18","author":[{"given":"Ravi S.","family":"Keshari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Silasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcis I.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Georgescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Chaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen J.T.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T.","family":"Esmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florea","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14642_bb0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/jth.14642_bb0015","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.thromres.2014.03.014","article-title":"Crosstalk between the coagulation and complement systems in sepsis","volume":"133","author":"Lupu","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14642_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00134-016-4607-x","article-title":"Should all septic patients be given systemic anticoagulation? No","volume":"43","author":"van der Poll","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1111\/jth.14642_bb0025","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14642_bb0030","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/0002-9343(89)80528-5","article-title":"Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia","volume":"87","author":"Emerson","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/jth.14642_bb0035","first-page":"227","article-title":"Antithrombin\u2010III prevents the lethal effects of Escherichia coli infusion in baboons","volume":"26","author":"Taylor","year":"1988","journal-title":"Circ Shock"},{"key":"10.1111\/jth.14642_bb0040","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI112902","article-title":"Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon","volume":"79","author":"Taylor","year":"1987","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.14642_bb0045","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14642_bb0050","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High\u2010dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/jth.14642_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/jth.14642_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/CCM.0000000000000763","article-title":"The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis","volume":"43","author":"Zarychanski","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1111\/jth.14642_bb0065","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","article-title":"The cytoprotective protein C pathway","volume":"109","author":"Mosnier","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.14642_bb0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1582-4934.2011.01454.x","article-title":"Pathophysiology, staging and therapy of severe sepsis in baboon models","volume":"16","author":"Taylor","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1111\/jth.14642_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(97)00042-X","article-title":"Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide","volume":"86","author":"Walenga","year":"1997","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14642_bb0080","first-page":"CD011782","article-title":"Pentasaccharides for the treatment of deep vein thrombosis","volume":"12","author":"Brandao","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jth.14642_bb0085","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"key":"10.1111\/jth.14642_bb0090","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood-2010-02-269746","article-title":"Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis","volume":"116","author":"Silasi\u2010Mansat","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14642_bb0095","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V95.5.1680.005k33_1680_1686","article-title":"The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis","volume":"95","author":"Taylor","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.14642_bb0100","doi-asserted-by":"crossref","first-page":"E6390","DOI":"10.1073\/pnas.1706818114","article-title":"Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis","volume":"114","author":"Keshari","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14642_bb0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/bloodadvances.2018029983","article-title":"Inhibition of contact\u2010mediated activation of factor XI protects baboons against S aureus\u2010induced organ damage and death","volume":"3","author":"Silasi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1111\/jth.14642_bb0110","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random\u2010effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1111\/jth.14642_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2307\/2532087","article-title":"Nonlinear mixed effects models for repeated measures data","volume":"46","author":"Lindstrom","year":"1990","journal-title":"Biometrics"},{"key":"10.1111\/jth.14642_bb0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0049-3848(02)00340-7","article-title":"In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation","volume":"107","author":"Linkins","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14642_bb0125","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1016\/S0021-9258(18)37825-6","article-title":"Physiologic inhibition of human activated protein C by alpha 1\u2010antitrypsin","volume":"263","author":"Heeb","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14642_bb0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis\u20103)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1111\/jth.14642_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0034-1398376","article-title":"Coagulation in patients with severe sepsis","volume":"41","author":"Levi","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14642_bb0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH04-06-0384","article-title":"Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low\u2010molecular\u2010weight heparin","volume":"92","author":"Olson","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14642_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/14728222.2011.553608","article-title":"Blood coagulation factor Xa as an emerging drug target","volume":"15","author":"Borensztajn","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/jth.14642_bb0150","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"10.1111\/jth.14642_bb0155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ni1525","article-title":"'Role reversal' for the receptor PAR1 in sepsis\u2010induced vascular damage","volume":"8","author":"Kaneider","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1111\/jth.14642_bb0160","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/ATVBAHA.118.311193","article-title":"Factor XII activation promotes platelet consumption in the presence of bacterial\u2010type long\u2010chain polyphosphate in vitro and in vivo","volume":"38","author":"Zilberman\u2010Rudenko","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14642_bb0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14642_bb0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00024382-199604000-00007","article-title":"Comparison of the capacity of rhTNF\u2010alpha and Escherichia coli to induce procoagulant activity by baboon mononuclear cells in vivo and in vitro","volume":"5","author":"Li","year":"1996","journal-title":"Shock"},{"key":"10.1111\/jth.14642_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0038-1650512","article-title":"Antithrombin\u2010mediated inhibition of factor VIIa\u2010tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin","volume":"76","author":"Lormeau","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14642_bb0180","first-page":"665","article-title":"The inactivation of antithrombin III by serum elastase in patients with surgical infections","volume":"56","author":"Cohen","year":"1990","journal-title":"Am Surg"},{"key":"10.1111\/jth.14642_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2052-0492-1-9","article-title":"Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome","volume":"1","author":"Venkata","year":"2013","journal-title":"J Intensive Care"},{"key":"10.1111\/jth.14642_bb0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.2631","article-title":"Nucleation of platelets with blood\u2010borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance","volume":"14","author":"Wong","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1111\/jth.14642_bb0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2004-05-2010","article-title":"Effect of fondaparinux on platelet activation in the presence of heparin\u2010dependent antibodies: a blinded comparative multicenter study with unfractionated heparin","volume":"105","author":"Savi","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.14642_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2016.02.009","article-title":"Fondaparinux upregulates thrombomodulin and the endothelial protein C receptor during early\u2010stage reperfusion in a rat model of myocardial infarction","volume":"141","author":"Guillou","year":"2016","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14642_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/TA.0b013e31821a83f0","article-title":"Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats","volume":"72","author":"Iba","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1111\/jth.14642_bb0210","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/cc6943","article-title":"Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats","volume":"12","author":"Iba","year":"2008","journal-title":"Crit Care"},{"key":"10.1111\/jth.14642_bb0215","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/cc6851","article-title":"Danaparoid sodium inhibits systemic inflammation and prevents endotoxin\u2010induced acute lung injury in rats","volume":"12","author":"Hagiwara","year":"2008","journal-title":"Crit Care"},{"key":"10.1111\/jth.14642_bb0220","doi-asserted-by":"crossref","first-page":"24314","DOI":"10.1074\/jbc.M804800200","article-title":"Analysis of proteinase\u2010activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity","volume":"283","author":"Rallabhandi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14642_bb0225","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.V78.2.364.364","article-title":"DEGR\u2010factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage","volume":"78","author":"Taylor","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.14642_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13054-017-1636-y","article-title":"Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram\u2010negative sepsis","volume":"21","author":"Schochl","year":"2017","journal-title":"Crit Care"},{"key":"10.1111\/jth.14642_bb0235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1538-7836.2005.01188.x","article-title":"The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia\u2010reperfusion injury","volume":"3","author":"Frank","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14642_bb0240","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index","volume":"67","author":"Walsh","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/jth.14642_bb0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41684-018-0217-2","article-title":"Nonhuman primate species as models of human bacterial sepsis","volume":"48","author":"Chen","year":"2019","journal-title":"Lab Anim (NY)"},{"key":"10.1111\/jth.14642_bb0250","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet Alfa for the reversal of factor Xa inhibitor activity","volume":"373","author":"Siegal","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14642","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622015732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622015732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:26:02Z","timestamp":1761535562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622015732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1538783622015732"],"URL":"https:\/\/doi.org\/10.1111\/jth.14642","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}